CB1 受体拮抗剂
英文名 | Rimonabant | CAS号 | 168273-06-1 |
试剂别名 |
ACOMPLIA; RIMONABANT; RIMONABANT(ACOMPLIA,SR141716); 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidinopyrazole-3-carboxamide; 1H-Pyrazole-3-carboxamide, 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl-; 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide; A 281; Sr 141716
|
分子式 | C22H21Cl3N4O |
产品编号 | APEB1429 | 分子量 | 463.79 |
MDL号 |
产品名称: | CB1 受体拮抗剂 |
英文名称: | Rimonabant |
英文别名: | ACOMPLIA; RIMONABANT; RIMONABANT(ACOMPLIA,SR141716); 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidinopyrazole-3-carboxamide; 1H-Pyrazole-3-carboxamide, 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl-; 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide; A 281; Sr 141716 |
中文别名: | 利莫那班 |
CAS No.: | 168273-06-1 |
分子式: | C22H21CL3N4O |
分子量: | 463.79 |
危险品级别: | |
HS符号: | |
危害声明: |